Economy

Alder Biopharmaceuticals Inc (ALDR) Analysts See $-1.21 EPS

A number of other equities analysts have also commented on the company.

The company closed its last trading session at $11.15. The stock of Alder Biopharmaceuticals Inc (NASDAQ:ALDR) has "Buy" rating given on Thursday, June 29 by Aegis Capital. Finally, BMO Capital Markets reiterated an "outperform" rating and set a $27.00 target price (down previously from $39.00) on shares of Alder BioPharmaceuticals in a research report on Wednesday, August 9th. Jefferies maintained the stock with "Buy" rating in Wednesday, July 27 report. (NASDAQ:ALDR). The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 2.10. They set an outperform rating and a $17.00 price target for the company. Alder BioPharmaceuticals, Inc. was incorporated in 2002 and is headquartered in Bothell, Washington. Alder BioPharmaceuticals has a 52 week low of $8.60 and a 52 week high of $34.64. The company's market cap is $755.00 million. The company's 50-day moving average is $21.98 and its 200 day moving average is $24.55.

Alder BioPharmaceuticals (NASDAQ:ALDR) last released its quarterly earnings results on Tuesday, August 8th. The biopharmaceutical company reported ($1.48) earnings per share for the quarter, topping analysts' consensus estimates of ($1.67) by $0.19. The business had revenue of $0.68 million during the quarter. In contrast to the year ago quarter EPS was at -1.05.

As of the latest earnings report the EPS was $-5.15 and is expected to be $-5.71 for the current year with 67,713,000 shares outstanding.

Let's have a look at some of the important valuation ratios of the Alder BioPharmaceuticals, Inc. "(NASDAQ:ALDR) Stock Rating Reaffirmed by Mizuho" was posted by Equities Focus and is the sole property of of Equities Focus.

ILLEGAL ACTIVITY NOTICE: This piece was originally posted by StockNewsTimes and is owned by of StockNewsTimes. The legal version of this report can be read at https://www.truebluetribune.com/2017/09/26/alder-biopharmaceuticals-inc-aldr-now-covered-by-analysts-at-cowen-and-company.html. This PT gives upside of 75.44 % from the stock close price of Alder BioPharmaceuticals (NASDAQ:ALDR). The shares were bought at an average cost of $10.00 per share, for a total transaction of $250,000.00. The transaction was disclosed in a filing with the SEC, which is available at this link.

Several institutional investors have recently bought and sold shares of ALDR. Bank of Montreal Can raised its position in Alder BioPharmaceuticals by 3,047.2% during the first quarter. American Century Companies Inc. grew its stake in Alder BioPharmaceuticals by 5.7% during the 1st quarter. Emerald Advisers Inc. PA now owns 410,415 shares of the biopharmaceutical company's stock valued at $13,449,000 after buying an additional 174,222 shares in the last quarter. Bank of New York Mellon Corp now owns 210,401 shares of the biopharmaceutical company's stock valued at $4,377,000 after acquiring an additional 9,218 shares in the last quarter. Finally, Voya Investment Management LLC raised its position in Alder BioPharmaceuticals by 8.4% during the second quarter. The company's lead product candidate includes ALD403, an antibody, which is in Phase II clinical trial to target calcitonin gene-related peptide for the prevention of migraine.



Like this

loading...
loading...

Latest


28 September 2017
Kinder Morgan (NYSE:KMI) Earns News Sentiment Rating of 0.17
COPYRIGHT VIOLATION NOTICE: This piece was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. This buyback authorization allows the pipeline company to repurchase up to 4.6% of its stock through open market purchases.

28 September 2017
Sell-Side Sees Upside & Positive Growth in Vornado Realty Trust (NYSE:VNO)
Vornado Realty Trust (NYSE:VNO) closed September 26 at $76.96, down -14.79% or $13.36 from its record high price of $90.32. A number of research analysts recently issued reports on VNO shares. 27 funds opened positions while 113 raised stakes.

28 September 2017
Nike sides with National Football League players in Trump showdown
Stills, as of late Saturday morning, had not weighed in on social media. "So therefore ain't no invite", tweeted LeBron James . The chaos of an incredible National Basketball Association off-season behind him, LeBron James has returned to centre stage.

28 September 2017
Ken Livingstone: Making offensive comments about Jews does not make you anti-Semitic
Asked about whether Holocaust denial being discussed at a Labour fringe, he said: "I think history is for all of us to discuss, all history is our common heritage to discuss and analyse".

28 September 2017
Moeen Ali powers England to thrilling victory
Having been dropped on 122, he was eyeing a double century until his freak injury left him writhing in agony. Lewis completed a chanceless century, off 94 balls, when he pulled Woakes for his 13th boundary.

28 September 2017
TriCo Bancshares (TCBK) EPS Estimated At $0.55
Following the completion of the sale, the executive vice president now owns 18,294 shares in the company, valued at $658,584. Moreover, Inv Counselors Of Maryland Ltd Liability Com has 1.04% invested in TriCo Bancshares (NASDAQ:TCBK).

28 September 2017
UEFA Champions League 2017/18: Manchester City 2-0 Shakhtar Donetsk
He said: "My feeling is that we were playing in this way last season, but in the box we were not good back then. Last season he was a lot of time injured and when he was fit I didn't count too much on him.

28 September 2017
Fortnite's Battle Royale Had Over One Million Players at Launch
But that didn't stop Epic from releasing the mode for free in the game anyway - and it's a gamble that's paid off tremendously.

28 September 2017
Lady Gaga thanks Beyoncé for support during illness battle
I am looking forward to touring again soon, but I have to be with my doctors right now so I can be strong and perform for you all for the next 60 years or more".

28 September 2017
'Some progress' made as contract talks resume between GM and striking workers
About 2,500 union workers at the assembly plant in Ingersoll, Ont., went on strike early last week after their contract expired. Both sides will meet at Quality Hotel and Suites in Woodstock on Wednesday - hopeful to reach a deal by the end of the week.